Vanda Pharmaceuticals Inc (VNDA)
5.03
-0.07
(-1.37%)
USD |
NASDAQ |
Nov 15, 09:38
Vanda Pharmaceuticals Cash and Short Term Investments (Quarterly): 376.26M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 376.26M |
| June 30, 2024 | 387.68M |
| March 31, 2024 | 394.14M |
| December 31, 2023 | 388.26M |
| September 30, 2023 | 489.86M |
| June 30, 2023 | 489.35M |
| March 31, 2023 | 501.50M |
| December 31, 2022 | 466.86M |
| September 30, 2022 | 454.79M |
| June 30, 2022 | 440.86M |
| March 31, 2022 | 435.18M |
| December 31, 2021 | 432.81M |
| September 30, 2021 | 405.97M |
| June 30, 2021 | 396.49M |
| March 31, 2021 | 378.16M |
| December 31, 2020 | 367.74M |
| September 30, 2020 | 348.55M |
| June 30, 2020 | 339.85M |
| March 31, 2020 | 312.33M |
| December 31, 2019 | 312.13M |
| September 30, 2019 | 237.78M |
| June 30, 2019 | 280.16M |
| March 31, 2019 | 267.84M |
| December 31, 2018 | 257.36M |
| September 30, 2018 | 240.58M |
| Date | Value |
|---|---|
| June 30, 2018 | 231.22M |
| March 31, 2018 | 248.83M |
| December 31, 2017 | 143.41M |
| September 30, 2017 | 139.88M |
| June 30, 2017 | 137.12M |
| March 31, 2017 | 137.76M |
| December 31, 2016 | 141.34M |
| September 30, 2016 | 142.58M |
| June 30, 2016 | 135.99M |
| March 31, 2016 | 138.33M |
| December 31, 2015 | 143.18M |
| September 30, 2015 | 144.32M |
| June 30, 2015 | 146.64M |
| March 31, 2015 | 134.33M |
| December 31, 2014 | 129.82M |
| September 30, 2014 | 56.09M |
| June 30, 2014 | 63.58M |
| March 31, 2014 | 100.40M |
| December 31, 2013 | 130.35M |
| September 30, 2013 | 142.17M |
| June 30, 2013 | 103.63M |
| March 31, 2013 | 110.93M |
| December 31, 2012 | 120.40M |
| September 30, 2012 | 134.40M |
| June 30, 2012 | 144.70M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
312.13M
Minimum
Dec 2019
501.50M
Maximum
Mar 2023
405.94M
Average
395.32M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 49.26M |
| Black Diamond Therapeutics Inc | 112.68M |
| Edgewise Therapeutics Inc | 492.54M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |